Nanotechnology for Diabetes: A Review
Journal Title: World Journal of Pharmaceutical Sciences - Year 2016, Vol 4, Issue 7
Abstract
This review article discusses the potential applications of nanoparticles and BioMEMS as drug delivery systems for diabetes treatment. This manuscript discusses polymeric nanoparticles, oral insulin administration using polysaccharides and polymeric nanoparticles, inhalable insulin nanoparticles formulations, and insulin delivery using BioMEMS. In addition polymeric nanoparticles and treatment of diabetes –associated symptoms are discussed. There are a few limitations in the use of conventionally available drug delivery systems for diabetes treatment. This article reviews the subject in brief with suitable references to original research articles and review articles on earlier and current research findings about various types of nanoparticles and BioMEMS in diabetes treatment and their limitations.
Authors and Affiliations
Prathiba V
Phytochemical analysis and identification of flavonoid “quercetin” from Jatropha gossypifolia l. (euphorbiaceae) leaf extract
Medicinal plants are the most exclusive source of life saving drugs for the majority of the world’s population. Jatropha gossypifolia Linn. well known plant of family Euphorbiaceae is used as a therapeutic agent. In the...
Preparation and characterization of L – Dopa loaded chitosan – based dry powder: Rescue / continuous supplement in Parkinson’s disease via inhalation
L – Dopa (LD) oral administration for controlling Parkinson's disease (PD) motor symptoms at the later stage will become inefficient pharmacodynamically due to the motor deteriorations result from LD fluctuated pharmacok...
Knowledge among final year student of pathological discharge in patients attending gynecology OPD
Women have so many medical problems due to the hormonal change with the age. Different abnormal discharges in women are common gynecological symptoms. Whilst most patients have benign disease, thorough investigation is n...
Dystonia: A systemic review
Dystonia is a development issue in which muscles contract automatically, causing dull or bending developments. The condition can influence one a player in your body (focal dystonia), at least two adjoining parts(segmenta...
Regulations for the development of biosimilar
Present article signifies the exigency for robust regulation involved in the development of biosimilars. The principle for the development of biosimilars included opting adequate reference product, manufacturing process...